PMGC HOLDINGS INC. Prepaid Expense and Other Assets, Current
PMGC HOLDINGS INC. (ELAB) had Prepaid Expense and Other Assets, Current of $504.60 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $504.60K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $502.54K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $461.24K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $770.10K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $504.60K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $502.54K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $461.24K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $770.10K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $791.05K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $842.20K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $868.46K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $787.85K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $923.44K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $902.05K 10-K · filed 2025-03-28 | $1.06M 10-K · filed 2024-03-29 |
| 2023-09-30 | $292.06M 10-Q · filed 2023-12-11 | |
| 2022-12-31 | $153.42K 10-K · filed 2024-03-29 | $153.42M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |